Intended for healthcare professionals

  1. Research
  2. Derivation and...
  3. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study
Research

Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study

BMJ 2007; 335 doi: https://doi.org/10.1136/bmj.39261.471806.55 (Published 19 July 2007) Cite this as: BMJ 2007;335:136

Related articles

See more

Cited by...

  • Atherosclerotic cardiovascular disease risk prediction: current state-of-the-art
  • Baseline characteristics among 101,407 people with myocardial infarction over nine-year time period: a population-based study using primary care data
  • Prediction of Cardiovascular Markers and Diseases Using Retinal Fundus Images and Deep Learning: A Systematic Scoping Review
  • COLOFIT: Development and internal-external validation of models using age, sex, faecal immunochemical and blood tests to optimise diagnosis of colorectal cancer in symptomatic patients
  • A Systematic Review and Meta-Analysis of the Predictive Power of China-PAR Against Cardiovascular Disease
  • Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study
  • Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank
  • PowerAI-CVD - the first Chinese-specific, validated artificial intelligence-powered in-silico predictive model for cardiovascular disease
  • Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study
  • Performance of the SCORE and Globorisk cardiovascular risk prediction models: a prospective cohort study in Dutch general practice
  • Socioeconomic status and modification of atherosclerotic cardiovascular disease risk prediction: epidemiological analysis using data from the atherosclerosis risk in communities study
  • IMPROVING CARDIOVASCULAR DISEASE RISK PREDICTION WITH MACHINE LEARNING USING MENTAL HEALTH DATA: A PROSPECTIVE UK BIOBANK STUDY
  • Regression discontinuity design to evaluate the effect of statins on myocardial infarction in electronic health records
  • An independent external validation of the QRISK3 cardiovascular risk prediction model applied to UK Biobank participants
  • Development and validation of a cardiovascular diseases risk prediction model for Chinese males (CVDMCM)
  • Association of Retinal Age Gap with Arterial Stiffness and Incident Cardiovascular Disease
  • Predicting the risk of prostate cancer in asymptomatic men: a cohort study to develop and validate a novel algorithm
  • Educational inequalities in statin treatment for preventing cardiovascular disease: cross-sectional analysis of UK Biobank
  • Performing risk stratification for COVID-19 when individual level data is not available - the experience of a large healthcare organization
  • GPs familiarity with and use of cardiovascular clinical prediction rules: a UK survey study
  • Impact of lowering the risk threshold for statin treatment on statin prescribing: a descriptive study in English primary care
  • Biomarkers versus traditional risk factors to predict cardiovascular events in very old adults: cross-validated prospective cohort study
  • Metabolic dysregulation of the lysophospholipid/autotaxin axis in the chromosome 9p21 gene SNP rs10757274
  • Prediction performance of a cardiovascular risk assessment tool using Stanford EHR data repository
  • Development and validation of prediction models to estimate risk of primary total hip and knee replacements using data from the UK: two prospective open cohorts using the UK Clinical Practice Research Datalink
  • Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation
  • Performance of a Framingham cardiovascular risk model among Indians and Europeans in New Zealand and the role of body mass index and social deprivation
  • Does bone mineral density improve the predictive accuracy of fracture risk assessment? A prospective cohort study in Northern Denmark
  • Managing dyslipidaemia for the primary prevention of cardiovascular disease
  • Can doctors and patients correctly estimate cardiovascular risk? A cross-sectional study in primary care
  • Incremental Value of Repeated Risk Factor Measurements for Cardiovascular Disease Prediction in Middle-Aged Korean Adults: Results From the NHIS-HEALS (National Health Insurance System-National Health Screening Cohort)
  • Improving life expectancy in people with serious mental illness: should we place more emphasis on primary prevention?
  • Global cardiovascular risk assessment in the primary prevention of cardiovascular disease in adults: systematic review of systematic reviews
  • Performance of the Atherosclerotic Cardiovascular Disease Pooled Cohort Risk Equations by Social Deprivation Status
  • Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: protocol for an overview of systematic reviews
  • Cardiovascular risk assessment and treatment in chronic inflammatory disorders in primary care
  • Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I)
  • Cohort study investigating the relationship between cholesterol, cardiovascular risk score and the prescribing of statins in UK primary care: study protocol
  • Predicting the 10-Year Risks of Atherosclerotic Cardiovascular Disease in Chinese Population: The China-PAR Project (Prediction for ASCVD Risk in China)
  • Statins are underused in recent-onset Parkinson's disease with increased vascular risk: findings from the UK Tracking Parkinson's and Oxford Parkinson's Disease Centre (OPDC) discovery cohorts
  • Isolated Systolic Hypertension in Young People Is Not Spurious and Should Be Treated: Con Side of the Argument
  • GPs' perspectives on managing the NHS Health Check in primary care: a qualitative evaluation of implementation in one area of England
  • Prediction models for cardiovascular disease risk in the general population: systematic review
  • Distribution of lifespan gain from primary prevention intervention
  • Perspectives in Primary Care: A Conceptual Framework and Path for Integrating Social Determinants of Health Into Primary Care Practice
  • Association Between a Healthy Heart Score and the Development of Clinical Cardiovascular Risk Factors Among Women: Potential Role for Primordial Prevention
  • High B-Type Natriuretic Peptide Hypertensives at Target Blood Pressure: Potential Role of {beta}-Blockers to Reduce Their Elevated Risk
  • Impact of provision of cardiovascular disease risk estimates to healthcare professionals and patients: a systematic review
  • How Does Cardiovascular Disease First Present in Women and Men?: Incidence of 12 Cardiovascular Diseases in a Contemporary Cohort of 1 937 360 People
  • How to develop a more accurate risk prediction model when there are few events
  • Twenty top papers--the ones that got away and the results of the top six poll
  • Validity of Vascular Calcification as a Screening Tool and as a Surrogate End Point in Clinical Research
  • Validation of the Framingham general cardiovascular risk score in a multiethnic Asian population: a retrospective cohort study
  • Development and validation of risk prediction algorithms to estimate future risk of common cancers in men and women: prospective cohort study
  • The evidence base for fat guidelines: a balanced diet
  • Lifestyle-Based Prediction Model for the Prevention of CVD: The Healthy Heart Score
  • Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: secondary analysis of observational study data
  • Cardiovascular and neuropsychiatric safety of varenicline and bupropion compared with nicotine replacement therapy for smoking cessation: study protocol of a retrospective cohort study using the QResearch general practice database
  • Survival analysis in hematologic malignancies: recommendations for clinicians
  • The performance of seven QPrediction risk scores in an independent external sample of patients from general practice: a validation study
  • The impact of NHS Health Checks on the prevalence of disease in general practices: a controlled study
  • Predicting risk of upper gastrointestinal bleed and intracranial bleed with anticoagulants: cohort study to derive and validate the QBleed scores
  • 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  • 2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
  • Patient-Accessible Tool for Shared Decision Making in Cardiovascular Primary Prevention: Balancing Longevity Benefits Against Medication Disutility
  • A coronary heart disease prediction model: the Korean Heart Study
  • Pre-Eclampsia and Future Cardiovascular Risk Among Women: A Review
  • Smoker, ex-smoker or non-smoker? The validity of routinely recorded smoking status in UK primary care: a cross-sectional study
  • Clinical prediction rules in practice: review of clinical guidelines and survey of GPs
  • Ethnicity and prediction of cardiovascular disease: performance of QRISK2 and Framingham scores in a UK tri-ethnic prospective cohort study (SABRE--Southall And Brent REvisited)
  • A New Approach to Residual Risk in Treated Hypertension--3P Screening
  • Cardiovascular risk scores: qualitative study of how primary care practitioners understand and use them
  • Derivation and validation of QStroke score for predicting risk of ischaemic stroke in primary care and comparison with other risk scores: a prospective open cohort study
  • Clinical Scores for Predicting Recurrence After Transient Ischemic Attack or Stroke: How Good are They?
  • Cardiovascular Risk Management After a Hypertensive Disorder of Pregnancy
  • Inclusion of Stroke in Cardiovascular Risk Prediction Instruments: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
  • Interplay of Coronary Artery Calcification and Traditional Risk Factors for the Prediction of All-Cause Mortality in Asymptomatic Individuals
  • Association Between Family History and Coronary Heart Disease Death Across Long-Term Follow-Up in Men: The Cooper Center Longitudinal Study
  • Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2
  • Cardiovascular risk age: concepts and practicalities
  • Comparisons of established risk prediction models for cardiovascular disease: systematic review
  • Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study
  • Distribution of 10-year and lifetime predicted risk for cardiovascular disease in the Indian Sentinel Surveillance Study population (cross-sectional survey results)
Back to top